| Literature DB >> 28985202 |
Chin Siang Ong1, Pooja Yesantharao1, Chen Yu Huang2, Gunnar Mattson1, Joseph Boktor1, Takuma Fukunishi1, Huaitao Zhang1, Narutoshi Hibino1.
Abstract
Recent advances have allowed for three-dimensional (3D) printing technologies to be applied to biocompatible materials, cells and supporting components, creating a field of 3D bioprinting that holds great promise for artificial organ printing and regenerative medicine. At the same time, stem cells, such as human induced pluripotent stem cells, have driven a paradigm shift in tissue regeneration and the modeling of human disease, and represent an unlimited cell source for tissue regeneration and the study of human disease. The ability to reprogram patient-specific cells holds the promise of an enhanced understanding of disease mechanisms and phenotypic variability. 3D bioprinting has been successfully performed using multiple stem cell types of different lineages and potency. The type of 3D bioprinting employed ranged from microextrusion bioprinting, inkjet bioprinting, laser-assisted bioprinting, to newer technologies such as scaffold-free spheroid-based bioprinting. This review discusses the current advances, applications, limitations and future of 3D bioprinting using stem cells, by organ systems.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28985202 DOI: 10.1038/pr.2017.252
Source DB: PubMed Journal: Pediatr Res ISSN: 0031-3998 Impact factor: 3.756